Loading categories...
CROs
Why Do Patients Drop Out of Clinical Trials Before the Study Ends?
Mid-study patient dropout is one of the most expensive forms of attrition in clinical rese...
Vamshi Kantoju
Global Clinical Trials 2026: How Global-by-Design Strategies Are Reshaping Sites, Sponsors, and Trial Operations
Global clinical trials 2026 are increasingly being designed with cross-border execution, r...
Deeksha Gitta
Rare Disease Clinical Trial Recruitment: Proven Strategies for Reaching Small Patient Populations
Rare disease clinical trial recruitment presents unique challenges that traditional enroll...
Deeksha Gitta
Virtual Site Audits: How CROs Are Adapting to Remote Oversight
In the world of clinical trials, ensuring compliance, data integrity, and patient safety t...
Mahesh Upadrista
Understanding FDA Diversity Guidance for Clinical Trials
FDA diversity guidance is redefining how the U.S. approaches clinical research and inclusi...
Deeksha Gitta
FDA Finalizes Decentralized Trial Guidance: Key Takeaways for Sponsors & Sites
A Trial That Broke Boundaries FDA guidance on decentralized clinical trials is reshaping h...
Mahesh UpadristaPage01of03
